Pyelonephritis medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 22: | Line 22: | ||
|} | |} | ||
†It's optional to begin with an initial intravenous dose of a long-acting parenteral antimicrobial, such like 400 mg dose of [[ciprofloxacin]], other choicees are 1 g of [[ceftriaxone]] or a consolidated 24-h dose of an [[aminoglycoside]]. | |||
Revision as of 20:18, 20 January 2014
Pyelonephritis Microchapters |
Diagnosis |
Treatment |
Case Studies |
Pyelonephritis medical therapy On the Web |
American Roentgen Ray Society Images of Pyelonephritis medical therapy |
Risk calculators and risk factors for Pyelonephritis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief:
Medical Therapy
- Before starting treatment for suspected pyelonephritis, a urine culture and susceptibility test should be done in order to select the empirical antimicrobial that covers the causing organism.
|
†It's optional to begin with an initial intravenous dose of a long-acting parenteral antimicrobial, such like 400 mg dose of ciprofloxacin, other choicees are 1 g of ceftriaxone or a consolidated 24-h dose of an aminoglycoside.
As practically all cases of pyelonephritis are due to bacterial infections, antibiotics are the mainstay of treatment. Mild cases may be treated with oral therapy, but generally intravenous antibiotics are required for the initial stages of treatment. The type of antibiotic depends on local practice, and may include fluoroquinolones (e.g. ciprofloxacin), beta-lactam antibiotics (e.g. amoxicillin or a cephalosporin), trimethoprim (or co-trimoxazole) or nitrofurantoin. Aminoglycosides are avoided due to their toxicity, but may be added for a short duration.
If the patient is unwell and septic, intravenous fluids may be administered to compensate for the reduced oral intake, insensible losses (due to the raised temperature) and vasodilation and to maximize urine output.
|
‡Treat IV until 24-48 patient afebrile, then start 2 weeks course of PO regimen in the above table.